Found: 4
Select item for more details and to access through your institution.
PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 9, p. 1, doi. 10.1002/pds.70007
- By:
- Publication type:
- Article
Characterizing Granulocytopenia Associated with Thiamazole in Patients with Hyperthyroidism Based on Real‐World Data from the MID‐NET in Japan.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 924, doi. 10.1002/cpt.2850
- By:
- Publication type:
- Article
Increased risk of hypocalcemia with decreased kidney function in patients prescribed bisphosphonates based on real-world data from the MID-NET<sup>®</sup> in Japan: a new-user cohort study.
- Published in:
- BMC Nephrology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12882-024-03553-7
- By:
- Publication type:
- Article
Prescription trend and lactic acidosis in patients prescribed metformin before and after the revision of package insert for allowing metformin administration to patients with moderately decreased kidney function based on real-world data from MID-NET® in Japan
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2023.1294696
- By:
- Publication type:
- Article